Milbemycin derivatives: modification at the C-5 position. 1994

S Naito, and T Nanba, and Y Owatari, and Y Nakada, and S Muramatsu, and J Ide
Medicinal Chemistry Research Laboratories, Sankyo Co., Ltd., Tokyo, Japan.

Protection of the hydroxyl group at the C-5 position of milbemycin A4 and D was carried out to investigate the influence of the C-5 hydroxyl group on the anthelmintic potency of these derivatives. Moreover, the hydroxyl group was converted into amide groups as bioisosters. Biological activities of these derivatives were measured against Nippostrongylus brasiliensis in vitro, and minimal concentrations which induce 100% immotility in worms were determined for each derivative. Biological testing revealed that the hydroxyl group at C-5 is a structural requirement for retaining anthelmintic activity.

UI MeSH Term Description Entries
D007559 Ivermectin A mixture of mostly avermectin H2B1a (RN 71827-03-7) with some avermectin H2B1b (RN 70209-81-3), which are macrolides from STREPTOMYCES avermitilis. It binds glutamate-gated chloride channel to cause increased permeability and hyperpolarization of nerve and muscle cells. It also interacts with other CHLORIDE CHANNELS. It is a broad spectrum antiparasitic that is active against microfilariae of ONCHOCERCA VOLVULUS but not the adult form. Eqvalan,Ivomec,MK-933,Mectizan,Stromectol,MK 933,MK933
D009559 Nippostrongylus A genus of intestinal nematode parasites belonging to the superfamily HELIGMOSOMATOIDEA, which commonly occurs in rats but has been experimentally transmitted to other rodents and rabbits. Infection is usually through the skin. Rat Nematode,Nematode, Rat,Nematodes, Rat,Rat Nematodes
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000871 Anthelmintics Agents that kill parasitic worms. They are used therapeutically in the treatment of HELMINTHIASIS in man and animal. Anthelmintic,Antihelmintic,Vermifuge,Vermifuges,Antihelmintics
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D018942 Macrolides A group of often glycosylated macrocyclic compounds formed by chain extension of multiple PROPIONATES cyclized into a large (typically 12, 14, or 16)-membered lactone. Macrolides belong to the POLYKETIDES class of natural products, and many members exhibit ANTIBIOTIC properties. Macrolide

Related Publications

S Naito, and T Nanba, and Y Owatari, and Y Nakada, and S Muramatsu, and J Ide
January 2002, Nucleic acids research. Supplement (2001),
S Naito, and T Nanba, and Y Owatari, and Y Nakada, and S Muramatsu, and J Ide
October 2006, Yao xue xue bao = Acta pharmaceutica Sinica,
S Naito, and T Nanba, and Y Owatari, and Y Nakada, and S Muramatsu, and J Ide
December 1983, The Journal of antibiotics,
S Naito, and T Nanba, and Y Owatari, and Y Nakada, and S Muramatsu, and J Ide
September 2009, Bioorganic & medicinal chemistry letters,
S Naito, and T Nanba, and Y Owatari, and Y Nakada, and S Muramatsu, and J Ide
October 1999, Journal of medicinal chemistry,
S Naito, and T Nanba, and Y Owatari, and Y Nakada, and S Muramatsu, and J Ide
September 2016, Organic & biomolecular chemistry,
S Naito, and T Nanba, and Y Owatari, and Y Nakada, and S Muramatsu, and J Ide
September 1992, The Journal of antibiotics,
S Naito, and T Nanba, and Y Owatari, and Y Nakada, and S Muramatsu, and J Ide
July 1994, The Journal of antibiotics,
S Naito, and T Nanba, and Y Owatari, and Y Nakada, and S Muramatsu, and J Ide
May 1978, The Journal of antibiotics,
S Naito, and T Nanba, and Y Owatari, and Y Nakada, and S Muramatsu, and J Ide
January 2000, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!